Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

about

Etanercept for treating axial spondyloarthritis.

P2860

Q38691419-3BE35D79-286A-42E7-B018-282B1E114F80

P2860

Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Item

http://www.wikidata.org/entity/Q39135959

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@en

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@nl

type

Item

label

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@en

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@nl

prefLabel

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@en

Therapies of Early, Advanced, ...... or Treat to Target Strategies.

@nl

P1476

Therapies of Early, Advanced, ...... for Treat to Target Strategies

@en

P2093

Angela Padula

http://www.w3.org/2001/XMLSchema#string

Gercek Can

http://www.w3.org/2001/XMLSchema#string

Ignazio Olivieri

http://www.w3.org/2001/XMLSchema#string

Salvatore D'Angelo

http://www.w3.org/2001/XMLSchema#string

P2860

Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)

Sulfasalazine for ankylosing spondylitis

Methotrexate for ankylosing spondylitis

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data.

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.

Treating rheumatoid arthritis to target: recommendations of an international task force.

P2888

s11926-017-0633-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-017-0633-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

N Akkoc

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28197884

http://www.w3.org/2001/XMLSchema#string

Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

about

P2860

P2860

Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698